Alcohol does not significantly affect pharmacokinetics of Kadian

Armen Hareyan's picture
Advertisement

Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, presented results of a Phase IV study of KADIAN

Advertisement